Penumbra, Inc. (PEN)
325.60
+1.41
(+0.43%)
USD |
NYSE |
May 07, 10:53
Penumbra Cash from Investing (Quarterly) : -225.65M for Dec. 31, 2025
Cash from Investing (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (Quarterly) Benchmarks
| Boston Scientific Corp. | -591.00M |
| Abbott Laboratories | -20.32B |
| Insulet Corp. | -- |
| Globus Medical, Inc. | -111.45M |
| Stryker Corp. | -185.00M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | 86.48M |
| Cash from Financing (Quarterly) | 5.057M |
| Free Cash Flow | 174.93M |
| Free Cash Flow Per Share (Quarterly) | 1.728 |
| Free Cash Flow to Equity (Quarterly) | 65.40M |
| Free Cash Flow to Firm (Quarterly) | 68.30M |
| Free Cash Flow Yield | 1.37% |